Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens
Ann Oncol
.
2005:16 Suppl 8:viii13-viii19.
doi: 10.1093/annonc/mdi962.
Authors
T Thigpen
1
,
G Stuart
,
A du Bois
,
M Friedlander
,
K Fujiwara
,
J P Guastalla
,
S Kaye
,
H Kitchener
,
G Kristensen
,
R Mannel
,
W Meier
,
B Miller
,
A Poveda
,
D Provencher
,
F Stehman
,
I Vergote
;
Gynecologic Cancer Intergroup
;
GOG
;
NCIC-CTG
;
AGO-OVAR
;
ANZGOG
;
JGOG
;
GINECO
;
SGCTG
;
MRC/NCRI
;
NSGO
;
RTOG
;
GEICO
;
EORTC
Affiliation
1
Department of Medicine, Division of Oncology, University of Mississippi Medical Center, Jackson 39216, USA. JTTHIGPEN@worldnet.att.net
PMID:
16239232
DOI:
10.1093/annonc/mdi962
No abstract available
Publication types
Consensus Development Conference
Research Support, Non-U.S. Gov't
MeSH terms
Clinical Trials as Topic / standards*
Combined Modality Therapy
Female
Humans
Ovarian Neoplasms / therapy*